Surmodics, Inc. stock is up 9.71% since 30 days ago. The next earnings date is Feb 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 73.08% of the previous 25 December’s closed higher than November.
Surmodics, Inc. provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices. The IVD segment designs, develops, and manufactures component products and technologies for diagnostics. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.